Location History:
- Stanford, CA (US) (2022)
- Hayward, CA (US) (2020 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Innovations by Sergio Leal-Ortiz
Introduction
Sergio Leal-Ortiz is a notable inventor based in Hayward, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for delivering biologically relevant cargo into non-adherent cells. With a total of 3 patents, his work is paving the way for advancements in cell reprogramming techniques.
Latest Patents
One of his latest patents focuses on "Apparatuses and methods using nanostraws to deliver biologically relevant cargo into non-adherent cells." This invention utilizes nanostraws to effectively deliver molecules such as DNA, RNA, and proteins into various non-adherent cells, including immune cells and plant cells. The methods ensure high cell viability and dosage control, making them suitable for clinical applications.
Another significant patent is for "Nanostraw well insert devices for improved cell transfection and viability." This invention describes apparatuses that include nanotubes extending through a membrane, allowing materials to pass into cells when electrical energy is applied. The device enhances cell growth viability and transfection efficiency, achieving rates greater than 70%. These innovations can be integrated into existing cell culturing processes to improve overall efficiency.
Career Highlights
Sergio Leal-Ortiz is currently affiliated with Leland Stanford Junior University, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in medical and agricultural fields.
Collaborations
He has collaborated with notable colleagues such as Yuhong Cao and Nicholas A Melosh, contributing to the advancement of innovative technologies in their respective fields.
Conclusion
Sergio Leal-Ortiz is a pioneering inventor whose work in nanotechnology and cell biology is making a significant impact. His patents reflect a commitment to enhancing the efficiency of biological delivery systems, which could lead to transformative applications in medicine and beyond.